Skip to playerSkip to main contentSkip to footer
Benzinga
  • 10/2/2024
Eli Lilly's valuation stands at $842 billion, 54x projected earnings. Orforglipron could be the first small-molecule weight-loss pill when it launches in 2026, giving Eli Lilly two-year lead before rivals catch

Recommended

0:47
Up next
Amazon Denies Plan to Display Tariff Costs on Haul Items After Report Draws White House Rebuke
Benzinga
0:42
Dollar Under Pressure: Wall Street Split Widens Ahead Of High-Stakes US Data
Benzinga
0:51
Trump Says He Knows 'Much More' Than Fed Chair Jerome Powell About Interest Rates At Michigan Rally
Benzinga
0:49
Melania Trump-Backed 'Take It Down Act' Passes, Targeting Revenge Porn and AI Deepfakes
Benzinga
0:51
Oscar Mayer And Jell-O Maker Kraft Heinz Feels Macro Economic Pinch, Cuts Profit Outlook
Benzinga
1:04
Jim Cramer Sees Eli Lilly As More Than A 'One-Trick Pony' After FDA Advisors Back Its Alzheimer's Drug: 'It's Ultimately Headed To A Trillion Dollar Valuation'
Benzinga
4:16
Piper's Sandler's Craig Johnson Puts $6,600 Target On $SPX For 2025
Benzinga
1:00
Demand Soars For Novo Nordisk's Weight-Loss Drug Wegovy Despite Supply Constraints And Eli Lilly Competition
Benzinga
6:39
What turns around the value stocks?
Benzinga
4:15
Something Is Happening In The Utilities Sector That Investors Should Watch Out For | $XLU
Benzinga
1:12
Warren Buffett's Berkshire Hathaway, Elon Musk's Tesla And Eli Lilly Could Be Next Trillion-Dollar Companies After Nvidia's Rapid Ascension: Jim Cramer
Benzinga
2:45
Can The S&P 500 Reach $6000 Before Year End? | Jay Woods, CMT, Chief Global Strategist, Freedom Markets
Benzinga
4:17
Apple Stock Dips After KeyBanc Cuts Rating On iPhone Sale Concerns: What Investors Need To Know
Benzinga
0:58
Charlie Munger Revealed What Was Left On His Bucket List Before He Died
Benzinga
0:37
Eli Lilly's Mounjaro Outpaces Novo Nordisk's Ozempic In Weight Loss Effectiveness, Study Shows
Benzinga
3:04
How End Of Month Buy And Sell Imbalances Effected Stock Movements
Benzinga
13:34
"The Second Half Of September Is When The Trouble Tends To Come" - Ryan Detrick, CMT, Carson Group
Benzinga
0:39
Apple Stock Drops 14% in 2025 As Growth, AI, And China Risks Weigh On Tech Giant
Benzinga
4:07
Nike Q1 Earnings Highlights: EPS Beats As North American Sales Slide, Shares Move Higher
Benzinga
1:00
Billionaire Bill Ackman's Hedge Fund Pershing Square To Go Public At $50 Per Share
Benzinga
1:11
Microsoft Races To The Top, Hits $3-Trillion Valuation, Challenges Apple's Throne
Benzinga
4:01
Is Japan The Right Country To Invest In Right Now? - Jeremy Schwartz, Global Chief Investment Officer @WisdomTreeFunds
Benzinga
1:40
Is Managing Volatility Really An Asset Class?
Benzinga
17:00
Volatility And Momentum In The Market - Cameron Dawson, CIO NewEdge Wealth
Benzinga
5:17
Housing stocks Not As Quiet As People Think - $TPH $BZH $PHM
Benzinga